BlueRock Therapeutics – The interviews were open to discussions rather than sticking to a question/answer format which was really informative as a candidate to learn more about the position, company, and other nuances that wouldn't otherwise be conveyed. | Comparably

BlueRock Therapeutics – The interviews were open to discussions rather than sticking to a question/answer format which was really informative as a candidate to learn more about the position, company, and other nuances that wouldn't otherwise be conveyed.

BlueRock Therapeutics Заявленная компания
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves. читать еще
Эта компания принимает отзывы от проверенных сотрудников
СОТРУДНИКИ
УЧАСТНИКИ
180
ИТОГО
РЕЙТИНГИ
5197
×
Оцените свою компанию